Communiqués ProPhase Labs, Inc.

Actions

PRPH

US74345W2070

Installations et services en soins de santé

Marché Fermé - OTC Markets Autres places de cotation 20:40:52 24/07/2026			Varia. 5j.	Varia. 1 janv.
0,0586 ^USD	+1,03%		-11,61%	-86,91%

30/06	ProPhase Labs, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
01/06	ProPhase Labs, Inc. : l'auditeur émet un doute sur la 'continuité de l'exploitation'	CI

Communiqués

09/07	ProPhase Labs : Amendment to Quarterly Report (Form 10-Q/A)	PU
07/07	ProPhase Labs : Amendment to Quarterly Report (Form 10-Q/A)	PU
15/04	ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform	AQ
17/03	ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity	AQ
03/02	ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative	AQ
02/02	Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd	AQ
26/01	ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture	AQ
22/01	ProPhase Labs Uplists from Pink Sheets to OTC Market	AQ
05/01	ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value	AQ
19/12	ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories	AQ
26/11	Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1	AQ
19/11	ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.	AQ
18/11	ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19	AQ
17/11	ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals	AQ
29/10/25	ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology	AQ
28/10/25	ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts	AQ
24/10/25	ProPhase Labs to Present at the 2025 ThinkEquity Conference	AQ
22/10/25	ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology	AQ
23/09/25	PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE	AQ
22/09/25	ProPhase Continues its Exploration of a Crypto Treasury Strategy	AQ
12/09/25	ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor	AQ
03/09/25	ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025	AQ
19/08/25	ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders	AQ
13/08/25	ProPhase Labs : presentation as of 8.13.2025	PU
13/08/25	ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025	AQ